BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260528T130000
DTEND;TZID=America/Halifax:20260528T140000
DTSTAMP:20260614T030957
CREATED:20260522T100019Z
LAST-MODIFIED:20260522T100019Z
UID:10000737-1779973200-1779976800@oncodaily.com
SUMMARY:NCCN Webinar - Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations
DESCRIPTION:The NCCN (National Comprehensive Cancer Network) educational webinar\, titled “Optimizing Patient Outcomes – Hepatocellular Carcinoma: Latest Systemic Therapy Recommendations\,” is scheduled for May 28\, 2026 from 1:00 PM to 2:00 PM EDT. \nThis program addresses the rapidly evolving systemic therapy landscape of hepatocellular carcinoma (HCC)\, specifically focusing on recent efficacy data regarding immunotherapy. The session provides a nuanced approach to individualizing treatment for patients with advanced stages of liver dysfunction\, helping clinicians decide between systemic therapy and best supportive care. \nDesigned for a multidisciplinary audience of physicians\, nurses\, pharmacists\, and physician associates\, the activity covers first-line and subsequent-line systemic therapy options. \nRegistration and course access are available through the official NCCN platform.
URL:https://oncodaily.com/event/hepatocellular-carcinoma-506400
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/05/1777295437547_11zon.webp
LOCATION:
END:VEVENT
END:VCALENDAR